Pharmacologic studies on 1-nitro-9-(5-dimethyl-aminopentylamino)-acridine and 1-nitro-10-(3-dimethylaminopropyl)-acridone. 1. Acute and subchronic action.
D000166:Acridines / Q000008:administration & dosage / Q000494:pharmacology / Q000633:toxicity*; D000818:Animals; D000970:Antineoplastic Agents; D001341:Autonomic Nervous System / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects; D004123:Dimethylamines / Q000008:administration & dosage / Q000494:pharmacology / Q000633:toxicity; D005260:Female; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007408:Intestinal Absorption; D007509:Irritants; D007928:Lethal Dose 50; D008297:Male; D008722:Methods; D051379:Mice; D009130:Muscle, Smooth / Q000187:drug effects; D009574:Nitro Compounds / Q000008:administration & dosage / Q000494:pharmacology / Q000633:toxicity; D051381:Rats
D000166:Acridines; D000970:Antineoplastic Agents; D004123:Dimethylamines; D007509:Irritants; D009574:Nitro Compounds